Skip to main content
  1. Right Decisions
  2. GGC - Clinical Guidelines
  3. Maternity
  4. Back
  5. Common obstetric problems, intrapartum labour ward
  6. Fetal Blood Sampling in Labour (627)
Announcements and latest updates

Right Decision Service newsletter: October 2024

Welcome to the Right Decision Service (RDS) newsletter for October 2024.

1.Contingency arrangements for RDS outages

Development of the contingency solutions to maximise RDS resilience and minimise risk of future outages is in progress, aiming for completion by Christmas. As a reminder, these contingency arrangements  are:

  • Optimising mobile app build process
  • Mobile app always to be downloadable.
  • Serialising builds to mobile app; separate mobile app build from other editorial and end-user processes
  • Load balancing – provides failover (also enables separation of editorial processes from other processes to improve performance.)

 

In the meantime, a gentle reminder to encourage users to download essential clinical toolkits to their mobile devices so that there is an offline version always available.

 

2. New deployment with improvements.

A new scheduled deployment with minor improvements drawn from support tickets, externally funded projects, information related to outages, and feature requests will take place in early December. Key improvements planned are:

  • Deep-linking to individual toolkits within the RDS mobile app. Each toolkit will now have its own direct URL and QR code, both accessible from the app. These can be used to download the toolkit directly where users already have the RDS app installed. If the user does not yet have the RDS app installed, they will be taken to the app store to install the app and immediately afterwards the toolkit will automatically open and download. Note that this will go live a few days later than the improvements below due to the need to link up the mobile front end to the changes in the content management system.
  • Introducing an Announcement Header field to replace the hardcoded "Announcements and latest updates" text. This will enable users to see at a glance the focus of new announcements.
  • Automated daily emptying of the recycling bin (with a 30 day rolling grace period)  in the content management system. A bug preventing complete emptying of the recycling bin contributed to one of the outages earlier this year.
  • Supporting multiple passcodes (ticket 6079)
  • Expanding accordion section to show location of a search result rather than requiring user coming from a search result to manually open all sections and search again for the term.
  • Displaying first accordion section Content text as a snippet on the search results page as a fallback if default/main content is not provided
  • Displaying the context of each search result in the form of a link to the relevant parent tool/section. This will help users to choose which search result is most likely to be appropriate for their needs.
  • As part of release of the new national benzodiazepine quality prescribing guidance toolkit sponsored by Scottish Government Effective Prescribing and Therapeutics, a digital tool to support creation of benzodiazepine tapering/withdrawal schedules.

We are also seeking approval to use the NHS Scotland logo and title for the RDS app on the app stores to help with audience engagement and clarity around the provenance of RDS.

3. RDS Search, Browse and Archive/Version control enhancements

We are still hopeful that user acceptance testing for at least the Search and browse enhancements can take place before Christmas. Thank you for your patience and understanding in waiting for these improvements. Timescales have been pushed back by old app migration challenges, work to address outages, and most recently implementing the contingency arrangements.

4. Support tickets

We are aware that there continue to be some issues around a number of RDS support tickets, in part due to constraints around visibility for the RDS team of the tickets in the existing  support portal. We are investigating the potential to move to a new support ticket requesting system from early in the new year. We will organise the proposed webinar around support ticket processes once we have confirmed the way forward with the system.

Table formatting

There is a known issue with alterations in formatting of some RDS tables which seems to have arisen as a result of the 17 October deployment. Tactuum is working on a fix and on implementing additional regression testing to prevent this issue recurring.

5. New RDS toolkits

Recently launched toolkits include:

NHS Lothian Infectious Diseases

Scottish Health Technologies Group – Technology Assessment recommendations

NHS Tayside Anaesthetics and Critical Care projects – an innovative toolkit which uses PowerAutomate to manage review and response to proposals for improvement projects.

If you would like to promote one of your new toolkits through this newsletter, please contact ann.wales3@nhs.scot

A number of toolkits are expected to go live before Christmas, including:

  • Focus on dementia
  • Highland Council Getting it Right for Every Child
  • Dumfries and Galloway Adult Support and Protection procedures
  • National Waiting Well toolkit
  • Fertility Scotland National Network
  • NHS Lothian postural care for care homes

6.Sign up to RDS Editors Teams channel

We have had a good response to the recent invitation to sign up to the new Teams channel for RDS editors. This provides a forum for editors to share learning, ideas and questions and we hope to hold regular webinars on topics of interest.  The RDS team is in the process of joining participants to the channel and we’d encourage all editors to take part, using the registration form – available in Providers section of the RDS Learning and Support area.

 

7. Evaluation projects

The RDS team has worked with colleagues in NHS Grampian and the Digital Health & Care Innovation Centre to evaluate the impact of the Prevent the progress of diabetes web and mobile app in a small-scale pilot project. This app provides access to local and national resources and services targeted at people with prediabetes, a history of gestational diabetes, or candidates for remission. After just 8 weeks of using the app, 94% of patients reported increased their knowledge and understanding of diabetes, and 88% said it had increased their confidence and motivation to make lifestyle changes, highlighting specific behaviour changes. The learning from this project is informing development of a service model based on tailored support for patient groups with, high, medium and low digital self-efficacy.

Please contact ann.wales3@nhs.scot if you would like to know more about this project.

  1. Training sessions for new editors (also serve as refresher sessions for existing editors) will take place on the following dates:

  • Friday 29th November 3-4 pm
  • Thursday 5 December 3.30 -4.30 pm

To book a place, please contact Olivia.graham@nhs.scot, providing your name, organisation, job role, and level of experience with RDS editing (none, a little, moderate, extensive.)

 

To invite colleagues to sign up to receive this newsletter, please signpost them to the registration form  - also available in End-user and Provider sections of the RDS Learning and Support area.   If you have any questions about the content of this newsletter, please contact his.decisionsupport@nhs.scot  If you would prefer not to receive future newsletters, please email Olivia.graham@nhs.scot and ask to be removed from the circulation list.

With kind regards

 

Right Decision Service team

Healthcare Improvement Scotland

 

The Right Decision Service:  the national decision support platform for Scotland’s health and care

Website: https://rightdecisions.scot.nhs.uk    Mobile app download:  Apple  Android

 

 

Fetal Blood Sampling in Labour (627)

Warning
Please report any inaccuracies or issues with this guideline using our online form

A guideline is intended to assist healthcare professionals in the choice of disease-specific treatments. 

Clinical judgement should be exercised on the applicability of any guideline, influenced by individual patient characteristics. Clinicians should be mindful of the potential for harmful polypharmacy and increased susceptibility to adverse drug reactions in patients with multiple morbidities or frailty. 

If, after discussion with the patient or carer, there are good reasons for not following a guideline, it is good practice to record these and communicate them to others involved in the care of the patient.

Definition

Fetal blood sample (FBS) refers to obtaining a sample of blood from the presenting part of the baby in utero, during labour.  It is used to measure fetal pH or lactate as a way of identifying hypoxaemia and acidosis and stratifying those who require urgent delivery.  

Acidosis reflects fetal hypoxaemia as when hypoxic, fetal metabolism changes from aerobic to anaerobic which results in the production of lactic acid.  This leads to a subsequent drop in fetal pH and provides a measure of the degree of hypoxaemia for the baby in labour.

Indications

The indications for FBS include:

  • pathological CTG in labour (cervix dilated >3 cm, membranes ruptured)

Pre-requisites

Before you start an FBS procedure, you must:

  • Start conservative measures and offer digital fetal scalp stimulation. Only continue with fetal blood sampling if the CTG trace remains pathological.

  • Confirm the position and dilatation of the cervix (>3 cm), station of the presenting part and ensure membranes are ruptured.

  • Explain the procedure to the woman and obtain her verbal consent (see below).

  • Ensure that the instruments are to hand and that the blood gas analyser is functioning.

  • Ensure there are no contraindications for the procedure.

Contraindications

The contraindications include:

  • An acute event, for example, cord prolapse, suspected placental abruption or suspected uterine rupture.
  • Acute fetal compromise as suggested by a prolonged ongoing fetal bradycardia of >3 minutes.

  • Risk of maternal- fetal infection transfer, for example maternal HIV, maternal hepatitis viruses or active herpes simplex virus.

  • Fetal bleeding disorders or suspected fetal bleeding disorders, for example haemophilia, maternal thrombocytopenia.

  • Prematurity, less than 34 weeks gestation (i.e. <34+0 weeks).

  • Face presentation.

  • The whole clinical picture indicates that the birth should be expedited, for example maternal sepsis, unstable pre-eclampsia.

  • Do not take a sample immediately following a prolonged deceleration.

Cautions

Be aware that for women with sepsis or significant meconium, fetal blood sampling results may be falsely reassuring. 

Obtaining consent

NICE guidelines 2017 recommend that when considering fetal blood sampling, explain the following to the woman and her birth companion(s):

  • Why the test is being considered and other options available, including the risks, benefits and limitations of each.
  • The blood sample will be used to measure the level of acid in the baby's blood, which may help to show how well the baby is coping with labour.

  • The procedure will require her to have a vaginal examination using a device similar to a speculum.

  • A sample of blood will be taken from the baby's head by making a small scratch on the baby's scalp. This will heal quickly after birth, but there is a small risk of infection.

  • What the different outcomes of the test may be (normal, borderline and abnormal) and the actions that will follow each result.

  • If a FBS cannot be obtained but there are fetal heart rate accelerations in response to the procedure, this is encouraging and in these circumstances expediting the birth may not be necessary.

  • If a FBS cannot be obtained and the cardiotocograph trace has not improved, expediting the birth will be advised.

  • A caesarean section or instrumental birth (forceps or ventouse) may be advised, depending on the results of the procedure.

Equipment

The sterile FBS pack contains as standard the following:

Sponge holder,  Amnioscope with attachable light source, 2 blades with blade holder, 5 capillary tubes and capillary tube holder, petroleum jelly, 6 large cotton swabs and 5 square green swabs.

In addition you will need

  • Lubricant gel –do not use Hibitane as this may alter the pH results
  • Ethyl chloride spray
  • Water for washing
  • Sterile gloves
  • Apron

Procedure

  • Ensure Labour Ward co-ordinator is aware you are undertaking this test prior to starting and ensure the blood gas analyser is ready to be used.

  • Place the woman either in a lithotomy or left lateral position with her right leg supported and abducted. Then drape the area around the perineum to provide a clean field.

  • Introduce the lubricated amnioscope. Direct the amnioscope posteriorly and sweep it anteriorly to catch the anterior lip of the cervix.

  • Remove the amnioscope’s obturator. Ideally, the cervix should not be visible. Try to visualise the fetal scalp clearly.

  • Clean the fetal scalp with a cotton wool swab, contamination with liquor or meconium can affect results. Spray the scalp with ethyl chloride to produce a reactive hyperaemia.

  • Apply a thin film of petroleum jelly with one of the large cotton wool swabs to increase surface tension on the fetal scalp; this encourages the formation of droplets of blood.

  • Insert the blade provided in the pack into the scalp to the full depth of the guard. Do not stroke the blade across the scalp as this may produce a lesion that is too large.

  • Collect the blood droplet into your capillary tube. At least two samples should be obtained. The second may be taken while the first is being analysed by an assistant.

  • Apply pressure to the fetal scalp with cotton wool swab at the end of the procedure if any bleeding is evident.

  • Reposition the mother comfortably and explain the results to her with your action plan.

Interpretation of results

A flow diagram for the interpretation of both pH and lactate is included at the end of this document.

pH rather than lactate is currently used within GGC for interpretation of fetal blood sampling, but please make sure you adhere to your local hospital policy.

The results should be interpreted taking into account the previous pH or lactate measurement, the rate of progress in labour and the clinical features of the woman and baby.

Where a FBS is indicated but a sample cannot be obtained and there is no improvement in the cardiotocograph trace, advise the woman that the birth should be expedited.

When planning to repeat an FBS, the time taken to obtain a sample must be taken into account

Post Delivery

If FBS is undertaken during labour, ensure paired cord gases are obtained at delivery and documented in the notes.

Fetal blood sampling flowchart

Editorial Information

Last reviewed: 19/04/2018

Next review date: 31/12/2022

Author(s): Julie Murphy.

Approved By: Obstetrics Clinical Governance Group

Document Id: 627

References

StratOG eLearning module, Fetal Blood Sampling, 2015, https://stratog.rcog.org.uk/tutorial/obstetrics/fetal-blood-sampling-5811

Intrapartum Care for healthy women and their babies, Clinical guideline [CG190], December 2014, updated  February 2017, https://www.nice.org.uk/guidance/cg190/chapter/Recommendations#monitoring-during-labour

RCOG Scientific Impact Paper No. 47, Is it time for UK obstetricians to accept Fetal Scalp lactate as an alternative to Fetal Scalp pH?  January 2015 https://www.rcog.org.uk/globalassets/documents/guidelines/scientific-impact-papers/sip_47.pdf